ArticleBMC nephrology2026
Fracture risk assessment in early-stage autosomal dominant polycystic kidney disease: a cross-sectional study using FRAX
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCompared with individuals with other chronic kidney disease (CKD), individuals with autosomal dominant polycystic kidney disease (ADPKD) may face increased fracture risk. This study provides the first clinical evaluation of fracture risk prediction in early-stage ADPKD using the FRAX
methodsIn this cross-sectional study, adult ADPKD patients with preserved kidney function were screened for fracture risk. Due to age eligibility criteria and data availability, fracture risk estimates could be calculated in 67 individuals using QFracture
resultsAll evaluated calculators were broadly in agreement at the group level, and the median fracture risk values for major osteoporotic and hip fractures remained consistently low. In our cohort, QFracture
conclusionsThis is the first study to explore the use of online fracture risk calculators in an early-stage ADPKD population. Although fracture risk calculators offer a practical and cost-effective approach for estimating fracture risk, their use in ADPKD requires cautious interpretation. Our findings indicate that age significantly influences the predicted risk, whereas neither the eGFR nor HtTKV, despite their relevance to kidney disease progression, were associated with any of the evaluated models. Future research should aim to refine fracture risk models by incorporating disease-specific variables and validating them in larger, prospective ADPKD cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.